Gemcitabine/Epirubicin/Paclitaxel Trials in Advanced Breast Cancer
February 1st 2001Numerous trials have shown that the pharmacokinetic interferences of epirubicin (Ellence)/paclitaxel (Taxol) combinations produce less pharmacodynamic effect than doxorubicin/paclitaxel regimens. Paclitaxel is more easily